Effectiveness and Implementation Study of STePS to Reduce Diabetes Emotional Distress in Teens
Delivered In-Person or Via Telehealth
Led by Jill Weissberg-Benchell, Ph.D. · Updated on 2026-05-29
360
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness and implementation of Supporting Teen Problem Solving STePS, an intervention designed to reduce diabetes-specific emotional distress in teenagers with Type 1 Diabetes Mellitus. The study includes 360 teens aged 14 to 18 from diverse backgrounds across six clinical sites. It compares STePS delivered in-person or via telehealth against an educational control group, focusing on improving emotional distress and preventing worsening blood sugar control over time.
Participants are randomly assigned to one of three groups STePS in-person, STePS via telehealth, or diabetes education via telehealth. Each group participates in a 4.5-month program consisting of nine sessions held twice monthly. STePS is a group-based behavioral intervention teaching emotion regulation and problem-solving skills to help teens manage diabetes-related distress. The study also examines how these delivery methods affect the uptake and sustainability of the intervention in real-world diabetes clinics.
Throughout the study, participants complete surveys at the start, immediately after the intervention, and at 6 and 12 months post-intervention to measure diabetes distress and blood sugar control Time in Range. Qualitative data from focus groups will explore participant and provider experiences. Researchers will assess recruitment, adherence, acceptability, costs, and program fidelity. The total participation spans about 16.5 months, including follow-up assessments to evaluate both clinical and practical outcomes of the intervention.
CONDITIONS
Brief Title
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
Research Team
J
Jill Weissberg-Benchell Professor, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
STePS (in‑person)
STePS (virtual)
Usual psychosocial diabetes education
What it is
A structured resilience‑promoting group intervention teaching emotion regulation, perspective taking, coping and problem‑solving in person
Same resilience‑promoting group intervention delivered virtually
Standard psychosocial diabetes education equal in time, group size and homework to trial comparator
Role in trial
Investigational arm, randomized assignment
Investigational arm, randomized assignment
Active comparator arm, randomized assignment
Primary use
To reduce diabetes‑specific emotional distress and build resilience
To reduce diabetes‑specific emotional distress and build resilience
Provide diabetes education matching intervention group experience
How it is given or performed
Delivered in person as group sessions teaching coping skills
Delivered virtually as group sessions teaching the same coping skills
Delivered virtually group education matching time and homework
Evidence status
Prior RCT showed long‑term reductions in diabetes distress and depressive symptoms at 3 years follow‑up
Efficacy assumed similar to in‑person format but not yet published
Common education interventions are standard but less effective at reducing long‑term distress compared to resilience programs
Important limitations
Effectiveness shown for combined STePS programs, not separated by delivery mode; virtual‑only efficacy is unproven
Virtual delivery efficacy not established separately
Education alone may not sustain long‑term reductions in distress without resilience training
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 14Years - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosed with Type 1 Diabetes Mellitus for at least 1 year
Using daily basal and bolus insulin
Fluent in English
Able to provide caregiver consent and teen assent
Able to access telehealth via a digital device
Focus on recruiting diverse teens including racial and ethnic minorities, low socioeconomic status, public aid recipients, or rural residents
You will not qualify if you...
Presence of cognitive or developmental disorders
Being a ward of the state
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual) for screening and enrollment
Outpatient Treatment
Duration - Approximately 4.5 months
Participants receive a 9-session group-based intervention, either in-person or via telehealth, aimed at reducing diabetes-specific emotional distress and building diabetes resilience, or receive diabetes education delivered virtually.
9 group sessions over about 4.5 months
Follow-up
Duration - Up to 12 months post intervention
Participants are assessed for diabetes distress and glycemic control at the end of the intervention and at 6 and 12 months post intervention to evaluate the lasting effects of the intervention.
3 follow-up assessments: at end of intervention, 6 months, and 12 months post intervention
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Similar Trials
Testing Weekly Tirzepatide Injections to Simplify Blood Sugar Control in Adults With Type 1 Diabetes Using Automated Insulin Pumps
Effectiveness and Implementation Study of STePS to Reduce Diabetes Emotional Distress in Teens
Delivered In-Person or Via Telehealth
Phase 1 Study of GNTI-122 Cell Therapy in Adults Recently Diagnosed with Type 1 Diabetes
Phase 1 Study of LY3938577 to Evaluate Safety, How It Works in the Body, and Blood Sugar Effects in Healthy Adults and Adults with Type 1 Diabetes
Phase 3 Randomized Study of Intravenous Teplizumab Versus Placebo in Children and Young Adults Aged 1 to 25 with Recently Diagnosed Stage 3 Type 1 Diabetes
Phase IIIa Study of OPF-310 Encapsulated Porcine Islet Cells to Evaluate Safety and Effectiveness in Adults Ages 35 to 65 with Unstable Type 1 Diabetes
Study to Test the Accuracy and Precision of the CareSens Air 3 Continuous Glucose Monitor in Adults with Type 1 Diabetes
Phase 2 Study of Weekly Tirzepatide Injections to Assess Metabolic Effects in Adults with Type 1 Diabetes
AI-Assisted Insulin Pump Setting Optimization for Adults with Type 1 Diabetes Using Continuous Glucose Monitoring
Open Label Phase 2 Study to Find the Best Dose of MTX228 Tablets for Adults With Type 1 Diabetes and Preserved Beta-Cell Function
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Supporting Teen Problem-Solving (STEPS) 3 year outcomes: Preventing diabetes-specific emotional distress and depressive symptoms in adolescents with type 1 diabetes.
Jill Weissberg-Benchell, Jenna B Shapiro, Fred B Bryant...